Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


18.02.2019

1 Arch Pediatr
1 Arch Virol
1 BMJ
13 Clin Infect Dis
2 Indian Pediatr
1 J Infect
1 J Infect Dis
1 J Virol
6 Lancet Infect Dis
3 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
3 PLoS One
1 Proc Natl Acad Sci U S A
26 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pediatr

  1. FISCHER A
    Vaccination of children.
    Arch Pediatr. 2019;26:55.
    PubMed     Text format    


    Arch Virol

  2. NURPEISOVA A, Kassenov M, Rametov N, Tabynov K, et al
    Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine.
    Arch Virol. 2019 Feb 10. pii: 10.1007/s00705-019-04147.
    PubMed     Text format     Abstract available


    BMJ

  3. DYER O
    Philippines measles outbreak is deadliest yet as vaccine scepticism spurs disease comeback.
    BMJ. 2019;364:l739.
    PubMed     Text format    


    Clin Infect Dis

  4. DESTEFANO F, Bodenstab HM, Offit PA
    Principal Controversies in Vaccine Safety in the United States.
    Clin Infect Dis. 2019 Feb 12. pii: 5316263. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. YOUSAFZAI MT, Qamar FN, Shakoor S, Saleem K, et al
    Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  6. BENTSI-ENCHILL AD, Hombach J
    Revised Global Typhoid Vaccination Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  7. STEELE AD, Parashar UD
    Rotavirus Vaccines set to make inroads in Asia.
    Clin Infect Dis. 2019 Feb 13. pii: 5316811. doi: 10.1093.
    PubMed     Text format    

  8. SEGALOFF HE, Leventer-Roberts M, Riesel D, Malosh RE, et al
    Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18.
    Clin Infect Dis. 2019 Feb 11. pii: 5314854. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. BLANCHARD ROHNER G, Chatzis O, Chinwangso P, Rohr M, et al
    Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jul 26. pii: 5059783. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. SKOWRONSKI DM, De Serres G, Orenstein WA
    Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.
    Clin Infect Dis. 2019 Feb 7. pii: 5308623. doi: 10.1093.
    PubMed     Text format    

  11. SCHWARTZ LM, Zaman K, Yunus M, Basunia AH, et al
    Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.
    Clin Infect Dis. 2019 Feb 12. pii: 5316286. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  13. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available

  14. WIESE AD, Huang X, Yu C, Mitchel EF, et al
    Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.
    Clin Infect Dis. 2019 Feb 16. pii: 5321113. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. CHURCH JA, Rukobo S, Govha M, Lee B, et al
    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
    Clin Infect Dis. 2019 Feb 16. pii: 5321771. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. SAHASTRABUDDHE S, Saluja T
    Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


    Indian Pediatr

  17. JAVADEKAR B, Ghosh A, Kompithra RZ, Awasthi S, et al
    Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months.
    Indian Pediatr. 2018;55:1050-1055.
    PubMed     Text format     Abstract available

  18. BALASUBRAMANIAN S, Shah A, Pemde HK, Chatterjee P, et al
    Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) Recommended Immunization Schedule (2018-19) and Update on Immunization for Children Aged 0 Through 18 Years.
    Indian Pediatr. 2018;55:1066-1074.
    PubMed     Text format     Abstract available


    J Infect

  19. GREEN CA, Sande CJ, Scarselli E, Capone S, et al
    Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    J Infect. 2019 Feb 8. pii: S0163-4453(19)30038.
    PubMed     Text format     Abstract available


    J Infect Dis

  20. GRAY GC
    Adenovirus 4 and 7 vaccine: New Body Armor for Marine Officer Trainees.
    J Infect Dis. 2019 Feb 6. pii: 5308337. doi: 10.1093.
    PubMed     Text format    


    J Virol

  21. VAN DIEPEN MT, Chapman R, Douglass N, Galant S, et al
    Prime boost immunisations with DNA, MVA and protein-based vaccines elicit robust HIV-1, Tier 2 neutralizing antibodies against the CAP256 superinfecting virus.
    J Virol. 2019 Feb 13. pii: JVI.02155-18. doi: 10.1128/JVI.02155.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  22. POVEY M, Henry O, Riise Bergsaker MA, Chlibek R, et al
    Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
    Lancet Infect Dis. 2019 Feb 11. pii: S1473-3099(18)30716.
    PubMed     Text format     Abstract available

  23. WHITE M, Idoko O, Sow S, Diallo A, et al
    Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials.
    Lancet Infect Dis. 2019 Feb 8. pii: S1473-3099(18)30674.
    PubMed     Text format     Abstract available

  24. MIKULSKA M, Cesaro S, de Lavallade H, Di Blasi R, et al
    Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).
    Lancet Infect Dis. 2019 Feb 7. pii: S1473-3099(18)30601.
    PubMed     Text format     Abstract available

  25. CORDONNIER C, Einarsdottir S, Cesaro S, Di Blasi R, et al
    Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).
    Lancet Infect Dis. 2019 Feb 7. pii: S1473-3099(18)30600.
    PubMed     Text format     Abstract available

  26. SEKKIDES O
    The use of vaccines to safeguard patients with haematological malignancies.
    Lancet Infect Dis. 2019 Feb 7. pii: S1473-3099(19)30037.
    PubMed     Text format    

  27. MACARTNEY K
    Long-term protection against varicella with two-dose combination measles-mumps-rubella-varicella vaccine.
    Lancet Infect Dis. 2019 Feb 11. pii: S1473-3099(18)30797.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  28. DOYLE JD, Chung JR, Kim SS, Gaglani M, et al
    Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:135-139.
    PubMed     Text format     Abstract available

  29. BLANTON L, Dugan VG, Abd Elal AI, Alabi N, et al
    Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
    MMWR Morb Mortal Wkly Rep. 2019;68:125-134.
    PubMed     Text format     Abstract available

  30. DOSHANI M, Weng M, Moore KL, Romero JR, et al
    Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness.
    MMWR Morb Mortal Wkly Rep. 2019;68:153-156.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  31. STEIN-ZAMIR C, Sokolov I, Abramson N, Shoob H, et al
    Pertussis Outbreak in Infants and an Immunization Campaign Based on Providing Pertussis Vaccine Doses at 6 Weeks, 10 Weeks, and 14 Weeks.
    Pediatr Infect Dis J. 2019;38:e63-e64.
    PubMed     Text format    


    PLoS One

  32. WILDE S, Jiang Y, Tafoya AM, Horsman J, et al
    Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
    PLoS One. 2019;14:e0197721.
    PubMed     Text format     Abstract available

  33. MEDISE BE, Soedjatmiko S, Rengganis I, Gunardi H, et al
    Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
    PLoS One. 2019;14:e0211784.
    PubMed     Text format     Abstract available

  34. CHAKRABARTI A, Grepin KA, Helleringer S
    The impact of supplementary immunization activities on routine vaccination coverage: An instrumental variable analysis in five low-income countries.
    PLoS One. 2019;14:e0212049.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  35. TEDIJANTO C, Olesen SW, Grad YH, Lipsitch M, et al
    Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora.
    Proc Natl Acad Sci U S A. 2018;115:E11988-E11995.
    PubMed     Text format     Abstract available


    Vaccine

  36. SHEN AK, Groom AV, Leach DL, Bridges CB, et al
    A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30120.
    PubMed     Text format     Abstract available

  37. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
    Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
    PubMed     Text format     Abstract available

  38. KESSELS J, Tarantola A, Salahuddin N, Blumberg L, et al
    Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.
    Vaccine. 2019 Feb 5. pii: S0264-410X(19)30105.
    PubMed     Text format     Abstract available

  39. RANDALL H, Kallen LE
    Using advocacy to increase investment in enteric vaccine development.
    Vaccine. 2019 Feb 5. pii: S0264-410X(18)31706.
    PubMed     Text format     Abstract available

  40. PARKER AR, Park MA, Harding S, Abraham RS, et al
    The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax(R)23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
    Vaccine. 2019 Feb 5. pii: S0264-410X(19)30098.
    PubMed     Text format     Abstract available

  41. HAQUE W, Haque J, Barai D, Rahman S, et al
    Distribution of rotavirus genotypes in Dhaka, Bangladesh, 2012-2016: Re-emergence of G3P[8] after over a decade of interval.
    Vaccine. 2018;36:6393-6400.
    PubMed     Text format     Abstract available

  42. DEDIEGO ML, Chiem K, Topham DJ
    Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
    Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240.
    PubMed     Text format     Abstract available

  43. REN Z, Zhao Y, Liu J, Ji X, et al
    Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
    Vaccine. 2018;36:5990-5998.
    PubMed     Text format     Abstract available

  44. SURAGH TA, Lamprianou S, MacDonald NE, Loharikar AR, et al
    Cluster anxiety-related adverse events following immunization (AEFI): An assessment of reports detected in social media and those identified using an online search engine.
    Vaccine. 2018;36:5949-5954.
    PubMed     Text format     Abstract available

  45. ALI M, Chang BA, Johnson KW, Morris SK, et al
    Incidence and aetiology of bacterial meningitis among children aged 1-59months in South Asia: systematic review and meta-analysis.
    Vaccine. 2018;36:5846-5857.
    PubMed     Text format     Abstract available

  46. RAMSAY LC, Anyiwe K, Li M, Macdonald L, et al
    Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30155.
    PubMed     Text format     Abstract available

  47. DOORNEKAMP L, de Jong W, Wagener MN, Goeijenbier M, et al
    Dutch healthcare professionals' opinion on vaccination and education to prevent infections in immunocompromised patients: A mixed-method study with recommendations for daily practice.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30160.
    PubMed     Text format     Abstract available

  48. HAMLET A, Jean K, Yactayo S, Benzler J, et al
    POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30159.
    PubMed     Text format     Abstract available

  49. ZHANG T, Cui L, Geng X, Yu X, et al
    Epidemiology study of pediatric primary intussusception aged </=24months in pre-rotavirus vaccine era of Jinan, China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30145.
    PubMed     Text format     Abstract available

  50. SHARP A, Coles S, Pegorie M, Harwood C, et al
    Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30089.
    PubMed     Text format     Abstract available

  51. AHMED MC, Heukelbach J, Weddih A, Filali-Maltouf A, et al
    Reduction of hospitalizations with diarrhea among children aged 0-5years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30164.
    PubMed     Text format     Abstract available

  52. ZENG Y, Yuan Z, Yin J, Han Y, et al
    Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
    PubMed     Text format     Abstract available

  53. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
    Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
    PubMed     Text format     Abstract available

  54. JALLOH MF, Jalloh MB, Albert A, Wolff B, et al
    Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
    Vaccine. 2019 Feb 9. pii: S0264-410X(19)30122.
    PubMed     Text format     Abstract available

  55. ZUK P, Zuk P, Lisiewicz-Jakubaszko J
    The anti-vaccine movement in Poland: The socio-cultural conditions of the opposition to vaccination and threats to public health.
    Vaccine. 2019 Feb 9. pii: S0264-410X(19)30158.
    PubMed     Text format     Abstract available

  56. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
    Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
    PubMed     Text format     Abstract available

  57. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
    Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
    Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
    PubMed     Text format     Abstract available

  58. WASAN EK, Syeda J, Strom S, Cawthray J, et al
    A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30134.
    PubMed     Text format     Abstract available

  59. HABER P, Moro PL, Ng C, Dores GM, et al
    Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
    PubMed     Text format     Abstract available

  60. HARAPAN H, Mudatsir M, Yufika A, Nawawi Y, et al
    Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
    Vaccine. 2019 Feb 7. pii: S0264-410X(19)30147.
    PubMed     Text format     Abstract available

  61. FORTANIER AC, Venekamp RP, Hoes AW, Schilder AGM, et al
    Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study.
    Vaccine. 2019 Feb 6. pii: S0264-410X(19)30149.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: